Evidence map›Paper›PMID 36290721›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Opposite Effect of Thyroid Hormones on Oxidative Stress and on Mitochondrial Respiration in COVID-19 Patients.

Claudia De Vitis, Carlo Capalbo, Alessandra Torsello, Christian Napoli, Valentina Salvati, Chiara Loffredo, Giovanni Blandino, Giulia Piaggio, Francesca Romana Auciello, Flaminia Pelliccia and 8 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Myxedema in Both Hyperthyroidism and Hypothyroidism: A Hormetic Response?International journal of molecular sciences · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Claudia De VitisDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0001-8899-2347
Carlo CapalboDepartment of Medical Oncology, Sant'Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0001-8445-6782
Alessandra TorselloDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.
Christian NapoliDepartment of Surgical and Medical Science and Translational Medicine, Sapienza University of Rome, 00181 Rome, Italy.ORCID 0000-0002-5775-2276
Valentina SalvatiScientific Direction, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Chiara LoffredoUnit of Anesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, 00189 Rome, Italy.
Giovanni BlandinoTranslational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Giulia PiaggioUOSD SAFU, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Roma, Italy.
Francesca Romana AucielloTranslational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Flaminia PellicciaUnit of Anesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, 00189 Rome, Italy.
Gerardo SalernoDepartment of Neuroscience, Mental Health, and Sensory Organs (NESMOS), Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0002-6597-1452
Maurizio SimmacoDepartment of Neuroscience, Mental Health, and Sensory Organs (NESMOS), Sapienza University of Rome, 00189 Rome, Italy.
Laura Di MagnoDepartment of Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0001-9446-8752
Gianluca CanettieriDepartment of Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0001-6694-2613
Flaminia ColuzziUnit of Anesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0001-7184-5519
Rita ManciniDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.
Monica RoccoDepartment of Surgical and Medical Science and Translational Medicine, Sapienza University of Rome, 00181 Rome, Italy.ORCID 0000-0001-8380-3607
Salvatore SciacchitanoDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0003-1492-5365
Sapienza University of Rome · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Pasteur · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThyroid hormones (TH)s are master regulators of mitochondrial activity and biogenesis. Nonthyroidal illness syndrome (NTIS) is generally considered an adaptative response to reduced energy that is secondary to critical illness, including COVID-19. COVID-19 has been associated with profound changes in the cell energy metabolism, especially in the cells of the immune system, with a central role played by the mitochondria, considered the power units of every cell. Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects and alters mitochondrial functions, both to influence its intracellular survival and to evade host immunity. AIM OF THE STUDY: This study was undertaken to analyze the oxidative balance and mitochondrial respiration in COVID-19 patients with and without NTIS to elucidate the role that thyroid hormones (TH)s play in this context.

methodsIn our cohort of 54 COVID-19 patients, admitted to our University Hospital during the COVID-19 pandemic, we evaluated the generation of reactive oxygen species (ROS) by measuring the serum levels of derivatives of reactive oxygen metabolites (dROMs), and we analyzed the antioxidant capacity by measuring the serum biological antioxidant potential (BAP). We then analyzed the mitochondrial respiration in peripheral blood mononuclear cells (PBMC)s of 28 of our COVID-19 patients, using the seahorse instrument (Agilent). Results were correlated with the serum levels of THs and, in particular, of FT3. In addition, the role of T3 on bioelectrical impedance analysis (BIA) and mitochondrial respiration parameters was directly evaluated in two COVID-19 patients with NTIS, in which treatment with synthetic liothyronine (LT3) was given both in vivo and in vitro.

resultsIn our COVID-19 patients with NTIS, the dROMs values were significantly lower and the BAP values were significantly higher. Consequently, the oxidative stress index (OSi), measured as BAP/dROMs ratio was reduced compared to that observed in COVID-19 patients without NTIS, indicating a protective role exerted by NTIS on oxidative stress. In our COVID-19 patients, the mitochondrial respiration, measured in PBMCs, was reduced compared to healthy controls. Those with NTIS showed a reduced maximal respiratory capacity and a reduced proton leak, compared to those with normal FT3 serum values. Such lowered mitochondrial respiratory capacity makes the cells more vulnerable to bioenergetic exhaustion. In a pilot study involving two COVID-19 patients with NTIS, we could reinforce our previous observation regarding the role of T3 in the maintenance of adequate peripheral hydroelectrolytic balance. In addition, in these two patients, we demonstrated that by treating their PBMCs with LT3, both in vitro and in vivo, all mitochondrial respiration parameters significantly increased.

conclusionsOur results regarding the reduction in the serum levels of the reactive oxygen species (ROS) of COVID-19 patients with NTIS support the hypothesis that NTIS could represent an adaptative response to severe COVID-19. However, beside this beneficial effect, we demonstrate that, in the presence of an acute reduction of FT3 serum levels, the mitochondrial respiration is greatly impaired, with a consequent establishment of a hypoenergetic state of the immune cells that may hamper their capacity to react to massive viral infection.

Indexed as

bioelectrical impedance analysis (BIA)biological antioxidant potential (BAP)COVID-19extracellular flux analyzermitochondrial respirationnonthyroidal illness syndrome (NTIS)oxidative stressreactive oxygen species (ROS)thyroid hormones (THs)

Identifiers

PMID36290721
PMCPMC9598114
OpenAlexW4303685569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.